Phase I study of cis-diamminedicholoroplatinum [cisplatin] in combination with ICRF-187 [dexrazoxane] in the treatment of advanced malignancies.

Trial Profile

Phase I study of cis-diamminedicholoroplatinum [cisplatin] in combination with ICRF-187 [dexrazoxane] in the treatment of advanced malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jul 2016

At a glance

  • Drugs Dexrazoxane (Primary) ; Cisplatin
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Jan 2010 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top